Rimantadine and oseltamivir demonstrate synergistic combination effect in an experimental infection with type A (H3N2) influenza virus in mice

Antiviral Chemistry & Chemotherapy
Angel S GalabovG Gegova


We studied the combination effect of rimantadine hydrochloride and oseltamivir phosphate on mice infected with influenza A/Aichi/2/68 (H3N2) virus. Compounds were simultaneously administered in a 5-day-treatment course, starting 4 h before intranasal infection with 10 or 20 viral 50% mouse lethal doses. Initially, we tested combinations of oseltamivir (0.05, 0.1 and 0.2 mg/kg/day) and rimantadine (2.5, 5.0 and 7.5 mg/kg/day). Significant differences were recorded between combination-treated groups, and groups with separately applied compounds and the placebo group, such as: protection index of oseltamivir with 5.0 or 7.5 mg/kg rimantadine varied between 34-41% and 43-87%, respectively, whereas the individual effects of oseltamivir, 5 mg/kg of rimantadine and 7.5 mg/kg of rimantadine were 0-10%, 0% and 18.7-29.6%, respectively; mean survival time in combination-treated groups was lengthened by 3.1-6.9 days, in oseltamivir groups by 0-1.9 days, and in rimantadine groups by 0.8-1.3 days at 5 mg/kg and 2.6-3.2 days at 7.5 mg/kg. The three-dimensional method of Prichard and Shipman characterized the combination effect as synergistic. Further, we studied the activity of 0.05 mg/kg/day of oseltamivir combined with 5 mg/kg of rimantadi...Continue Reading


Mar 4, 1977·Annals of the New York Academy of Sciences·E C Herrmann, J A Herrmann
Oct 1, 1990·Antiviral Research·Mark N Prichard, C Shipman
Oct 1, 1986·The Journal of Antimicrobial Chemotherapy·F G Hayden
Aug 1, 1965·The Biochemical Journal·A Lwoff
Apr 1, 1980·Antimicrobial Agents and Chemotherapy·S Z WilsonR B Couch
Oct 1, 1980·Antimicrobial Agents and Chemotherapy·F G HaydenR Simons
Aug 10, 2000·Antiviral Research·J L McKimm-Breschkin
Jun 29, 2001·Antiviral Research·M ZambonGlobal Neuraminidase Inhibitor Susceptibility Network
Nov 25, 2004·Antimicrobial Agents and Chemotherapy·Elena A GovorkovaRobert G Webster
Dec 24, 2005·The New England Journal of Medicine·Menno D de JongJeremy Farrar


Sep 13, 2014·The Lancet Infectious Diseases·Jake DunningInternational Severe Acute Respiratory and Emerging Infection Consortium (ISARIC)
Mar 26, 2013·Antiviral Research·Mélanie SamsonGuy Boivin
Apr 10, 2009·Expert Opinion on Drug Safety·Patricia Schirmer, Mark Holodniy
Feb 19, 2008·Antiviral Research·Brian E Gilbert, Matthew T McLeay
Oct 17, 2008·Respirology : Official Journal of the Asian Pacific Society of Respirology·Samson S Y Wong, Kwok-Yung Yuen
Aug 2, 2016·Biomedicine & Pharmacotherapy = Biomédecine & Pharmacothérapie·Elitsa L PavlovaLora Simeonova
Aug 16, 2016·Journal of Molecular Biology·Dror AssaIsaiah T Arkin
Mar 20, 2010·The Journal of Antimicrobial Chemotherapy·James R Smith
Aug 1, 2010·Viruses·Elena A Govorkova, Robert G Webster
Dec 17, 2008·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·F G Hayden
Jul 10, 2010·Drugs·David A BoltzElena A Govorkova
May 10, 2012·Nihon rinsho. Japanese journal of clinical medicine·Makoto Miki, Akira Watanabe
Nov 22, 2014·The Cochrane Database of Systematic Reviews·Márcia G Alves GalvãoAntonio J L Alves da Cunha
Nov 11, 2009·Antimicrobial Agents and Chemotherapy·Donald F SmeeYousuke Furuta

Related Concepts

Antiviral Agents
Canis familiaris
Dose-Response Relationship, Drug
Drug Administration Schedule
Drug Augmentation
Mouse, Inbred ICRC
Orthomyxoviridae Infections

Related Feeds

Antivirals (ASM)

Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.


Antivirals are medications that are used specifically for treating viral infections. Discover the latest research on antivirals here.